
Strategic healthcare and life sciences leader with experience across agency and in-house pharmaceutical environments, with expertise in launch execution and neurological rare diseases. Known for building trust-based relationships with colleagues and key opinion leaders (KOLs) to drive alignment, credibility, and meaningful impact in highly regulated environments—while keeping patients at the center of every decision.